Future Medications and Newer Drugs

3158 Words Feb 23rd, 2018 13 Pages
Anxiety (Social Phobia)
Anxiety disorders affect more than 40 million adults in the U.S., with about 15 million of those suffering from acute social phobia, according to the National Institute of Mental Health. The drug, which has a unique mechanism of action, is administered in an intranasal spray and acts with rapid-onset on peripheral receptors from nasal chemosensory neurons that act on the hypothalamic-limbic system in the brain, which is thought to be the primary center of emotion.
In clinical trials, it was shown to improve social performance and social interaction anxiety within 10 minutes of administration.
Attention-Deficit/Hyperactivity Disorder (ADHD) – ADHD is one of the most common reasons children in the United States are referred for mental health services and affects as many as one in every 20 children, according to Mental Health America.
• A potential medicine in development for ADHD is an agonist of neuronal nicotinic receptors (NNR). NNRs serve as key regulators of nervous system functions. When certain neurotransmitters bind to an NNR, the receptor normalizes chemical signaling in the brain, allowing neurons to communicate properly. This results in increased signaling when the nervous system is under-stimulated and decreased signaling when the nervous system is overstimulated.
• A new drug with a nonstimulant mechanism of…